Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Yamashita, Motohiro"" wg kryterium: Autor


Tytuł :
Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
Autorzy :
Soh J; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. .
Toyooka S; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Okumura N; Department of Thoracic Surgery, Kurashiki Central Hospital, Kurashiki, Japan.
Nakamura H; Division of General Thoracic Surgery, Tottori University Hospital, Yonago, Japan.
Nakata M; Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan.
Yamashita M; Department of Thoracic Surgery, Shikoku Cancer Center, Matsuyama, Japan.
Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan.
Aoe M; Department of Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University, Kyoto, Japan.
Date H; Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2019 Nov; Vol. 24 (11), pp. 1367-1376. Date of Electronic Publication: 2019 Jul 16.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Non-Small-Cell Lung/*pathology
Lung Neoplasms/*drug therapy
Lung Neoplasms/*pathology
Adenocarcinoma/drug therapy ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Carboplatin/administration & dosage ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Chemotherapy, Adjuvant ; Female ; Humans ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Tegafur/administration & dosage ; Treatment Outcome ; Uracil/administration & dosage
Czasopismo naukowe
Tytuł :
Outcomes and prognostic factors after pulmonary metastasectomy in patients with colorectal cancer with previously resected hepatic metastases.
Autorzy :
Shimizu K; Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Gunma, Japan. Electronic address: .
Ohtaki Y; Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Gunma, Japan.
Okumura T; Department of Surgery, School of Medicine, University Hospital Mizonokuchi, Teikyo University, Kanagawa, Japan.
Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Horio H; Department of Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Takenoyama M; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.
Yamashita M; Division of General Thoracic Surgery, Shikoku Cancer Center, Ehime, Japan.
Hyodo I; Division of Gastroenterology Clinical Medicine Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Mori K; Clinical Research Support Center, Shizuoka Cancer Center, Shizuoka, Japan.
Kondo H; General Thoracic Surgery, School of Medicine, Kyorin University, Tokyo, Japan.
Pokaż więcej
Źródło :
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2019 May; Vol. 157 (5), pp. 2049-2057.e1. Date of Electronic Publication: 2019 Jan 11.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Hepatectomy*/adverse effects
Hepatectomy*/mortality
Metastasectomy*/adverse effects
Metastasectomy*/mortality
Pneumonectomy*/adverse effects
Pneumonectomy*/mortality
Colorectal Neoplasms/*pathology
Liver Neoplasms/*surgery
Lung Neoplasms/*surgery
Aged ; Carcinoembryonic Antigen/blood ; Colorectal Neoplasms/blood ; Colorectal Neoplasms/mortality ; Disease-Free Survival ; Female ; Humans ; Japan ; Liver Neoplasms/blood ; Liver Neoplasms/mortality ; Liver Neoplasms/secondary ; Lung Neoplasms/blood ; Lung Neoplasms/mortality ; Lung Neoplasms/secondary ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł :
Surgical outcomes in 13 patients with bronchopulmonary carcinoid tumors including one recurrent oncocytic carcinoid tumor.
Autorzy :
Ueno T; Department of Thoracic Surgery, National Hospital Organization, Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan. .
Maki Y; Department of Thoracic Surgery, National Hospital Organization, Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Sugimoto R; Department of Thoracic Surgery, National Hospital Organization, Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Yamashita M; Department of Thoracic Surgery, National Hospital Organization, Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Nakata K; Department of Thoracic Surgery, National Hospital Organization, Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Sugawara Y; Department of Diagnostic Radiology, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan.
Nishimura R; Department of Pathology, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan.
Teramoto N; Department of Pathology, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan.
Pokaż więcej
Źródło :
General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2019 May; Vol. 67 (5), pp. 486-489. Date of Electronic Publication: 2018 Jul 03.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoid Tumor/*surgery
Lung Neoplasms/*surgery
Neoplasm Recurrence, Local/*surgery
Adult ; Aged ; Carcinoid Tumor/diagnostic imaging ; Carcinoid Tumor/pathology ; Female ; Fluorodeoxyglucose F18 ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Positron-Emission Tomography ; Retrospective Studies ; Survival Rate ; Tomography, X-Ray Computed ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer.
Autorzy :
Tanaka F; Second Department of Surgery, University of Occupational and Environmental Health, Kitakyusyu, Japan. Electronic address: .
Yokomise H; Department of General Thoracic Surgery, Breast and Endocrinological Surgery, Faculty of Medicine, Kagawa University, Miki, Japan.
Soejima T; Department of Radiation Oncology, Hyogo Cancer Center, Akashi, Japan.
Uramoto H; Division of Thoracic Surgery, Kanazawa Medical University, Uchinada, Japan.
Yamanaka T; Department of Biostatistics, Yokohama City University, Yokohama, Japan.
Nakagawa K; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.
Yamamoto N; Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Nishimura Y; Department of Radiation Oncology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.
Niwa H; Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Okada M; Department of Thoracic Surgery, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Nakagawa T; Department of Thoracic Surgery, Tenri Hospital, Tenri, Japan.
Yamashita M; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2018 Oct; Vol. 106 (4), pp. 1018-1024. Date of Electronic Publication: 2018 Jun 08.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Neoplasm Staging*
Carcinoma, Non-Small-Cell Lung/*therapy
Esophagectomy/*methods
Lung Neoplasms/*therapy
Pneumonectomy/*methods
Postoperative Care/*methods
Aged ; Carcinoma, Non-Small-Cell Lung/diagnosis ; Chemoradiotherapy/methods ; Disease Progression ; Endosonography ; Feasibility Studies ; Female ; Follow-Up Studies ; Humans ; Image-Guided Biopsy ; Induction Chemotherapy/methods ; Lung Neoplasms/diagnosis ; Male ; Middle Aged ; Radiation Dosage ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
Autorzy :
Toyooka S; Department of General Thoracic, Breast and Endocrinological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan; Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. Electronic address: .
Okumura N; Department of Thoracic Surgery, Kurashiki Central Hospital, Kurashiki, Japan.
Nakamura H; Division of General Thoracic Surgery, Tottori University Hospital, Yonago, Japan.
Nakata M; Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan.
Yamashita M; Department of Thoracic Surgery, Shikoku Cancer Center, Matsuyama, Japan.
Tada H; Division of General Thoracic Surgery, Suita Tokushukai Hospital, Osaka, Japan.
Kajiwara S; Department of Surgery, Uwajima City Hospital, Uwajima, Japan.
Watanabe N; Department of Breast Surgery, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
Okada M; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan.
Aoe M; Department of Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Soh J; Department of General Thoracic, Breast and Endocrinological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Miyoshi S; Department of General Thoracic, Breast and Endocrinological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Matsuo K; Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Date H; Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło :
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2018 May; Vol. 13 (5), pp. 699-706. Date of Electronic Publication: 2018 Mar 02.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Tegafur/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Carboplatin/administration & dosage ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemotherapy, Adjuvant ; Female ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Prospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł :
Feasibility Trial of Oral UFT after Platinum-based Adjuvant Chemotherapy in Patients with Resected Non-small Cell Lung Cancer.
Autorzy :
Sawada S; Department of Thoracic Surgery, Japanese Red Cross Society Himeji Hospital, Himeji, Hyogo 670-8540, .
Sugimoto R
Ueno T
Yamashita M
Pokaż więcej
Źródło :
Acta medica Okayama [Acta Med Okayama] 2017 Dec; Vol. 71 (6), pp. 513-518.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Chemotherapy, Adjuvant ; Feasibility Studies ; Female ; Humans ; Male ; Middle Aged ; Platinum/therapeutic use ; Tegafur/therapeutic use ; Uracil/therapeutic use
SCR Protocol :
1-UFT protocol
Czasopismo naukowe
Tytuł :
A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
Autorzy :
Saka H; Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Aichi, Japan. .; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan. .; 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan. .
Kitagawa C; Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Aichi, Japan.; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Ichinose Y; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Takenoyama M; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Ibata H; Department of Respiratory Medicine, National Hospital Organization Mie Chuo Medical Center, Mie, Japan.
Kato T; Department of Respiratory Medicine, National Hospital Organization Nagara Medical Center, Gifu, Japan.
Takami K; Department of Respiratory Medicine, National Hospital Organization Osaka Medical Center, Osaka, Japan.
Yamashita M; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
Maeda T; Department of Medical Oncology, National Hospital Organization Yamaguchi Ube Medical Center, Yamaguchi, Japan.
Takeo S; Department of Thoracic Surgery, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Ueda H; Department of Surgery, National Hospital Organization Fukuoka Hospital, Fukuoka, Japan.
Okabayashi K; Department of Thoracic Surgery, National Hospital Organization Fukuoka Higashi Medical Center, Fukuoka, Japan.
Nagashima S; Department of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
Oka T; Department of Surgery, National Hospital Organization Ureshino Medical Center, Saga, Japan.
Kouso H; Department of Thoracic Surgery, National Hospital Organization Oita Medical Center, Oita, Japan.
Fukuyama S; Department of Thoracic Surgery, National Hospital Organization Beppu Medical Center, Oita, Japan.
Yoshimoto K; Department of Thoracic Surgery, National Hospital Organization Minami Kyushu National Hospital, Kagoshima, Japan.
Shimokawa M; Clinical Research Center, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Saito AM; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Ito S; Clinical Research Center, National Hospital Organization, Tokyo, Japan.
Pokaż więcej
Źródło :
Trials [Trials] 2017 Sep 15; Vol. 18 (1), pp. 429. Date of Electronic Publication: 2017 Sep 15.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Pneumonectomy*/adverse effects
Carcinoma, Non-Small-Cell Lung/*therapy
Dendritic Cells/*drug effects
Dendritic Cells/*transplantation
Galactosylceramides/*therapeutic use
Immunotherapy, Adoptive/*methods
Lung Neoplasms/*therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Clinical Protocols ; Dendritic Cells/immunology ; Disease-Free Survival ; Female ; Galactosylceramides/adverse effects ; Humans ; Japan ; Lung Neoplasms/immunology ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Lymphocytes, Tumor-Infiltrating/immunology ; Male ; Middle Aged ; Natural Killer T-Cells/immunology ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Research Design ; Time Factors ; Treatment Outcome ; Vinblastine/administration & dosage ; Vinblastine/analogs & derivatives ; Vinorelbine ; Young Adult
Czasopismo naukowe
Tytuł :
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.
Autorzy :
Watanabe M; Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Kawaguchi T; Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan; National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
Isa SI; Clinical Research Center, Department of Thoracic Oncology, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
Ando M; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Aichi, Japan.
Tamiya A; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
Kubo A; Division of Respiratory Medicine and Allergology, Aichi Medical University School of Medicine, Aichi, Japan; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Saka H; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Takeo S; Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Adachi H; Department of Thoracic Surgery, National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.
Tagawa T; Department of Thoracic Surgery, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
Kawashima O; Department of Thoracic Surgery, National Hospital Organization Shibukawa Medical Center, Gunma, Japan.
Yamashita M; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
Kataoka K; Department of Thoracic Surgery, National Hospital Organization Iwakuni Clinical Center, Yamaguchi, Japan.
Ichinose Y; Clinical Research Institute, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Takeuchi Y; Department of General Thoracic Surgery, National Hospital Organization Toneyama National Hospital, Osaka, Japan.
Watanabe K; Department of Thoracic Surgery, National Hospital Organization Yokohama Medical Center, Kanagawa, Japan.
Matsumura A; Department of Surgery, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
Koh Y; Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan. Electronic address: .
Pokaż więcej
Źródło :
EBioMedicine [EBioMedicine] 2017 Jul; Vol. 21, pp. 86-93. Date of Electronic Publication: 2017 Jun 07.
Typ publikacji :
Journal Article
MeSH Terms :
Genotyping Techniques*/methods
Genotyping Techniques*/standards
Multiplex Polymerase Chain Reaction*/methods
Multiplex Polymerase Chain Reaction*/standards
Mutation*
Carcinoma, Non-Small-Cell Lung/*genetics
ErbB Receptors/*genetics
Lung Neoplasms/*genetics
Alleles ; Carcinoma, Non-Small-Cell Lung/diagnosis ; DNA Mutational Analysis ; Exons ; Humans ; Lung Neoplasms/diagnosis ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Eight cases of salvage pulmonary resection for residual disease or isolated local recurrence detected after definitive chemoradiotherapy for N2 Stage-IIIA lung cancer.
Autorzy :
Sawada S; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan. Electronic address: .
Suehisa H; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Ueno T; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Yamashita M; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Pokaż więcej
Źródło :
Asian journal of surgery [Asian J Surg] 2017 Apr; Vol. 40 (2), pp. 95-99. Date of Electronic Publication: 2015 Sep 08.
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy/*methods
Lung Neoplasms/*pathology
Lung Neoplasms/*therapy
Neoplasm, Residual/*surgery
Pneumonectomy/*methods
Salvage Therapy/*methods
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Aged ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/therapy ; Disease-Free Survival ; Female ; Humans ; Japan ; Kaplan-Meier Estimate ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Pneumonectomy/mortality ; Prognosis ; Retrospective Studies ; Risk Assessment ; Sampling Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001.
Autorzy :
Okumura N; Department of Thoracic Surgery, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, 710-8602, Japan. .
Sonobe M; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoinkawara-cho, Sakyo-ku, Kyoto, Japan.
Okabe K; Division of Thoracic Surgery, Yamaguchi Ube Medical Center, 685 Higashikiwa, Ube, Japan.
Nakamura H; Division of General Thoracic Surgery, Department of Surgery, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Japan.
Kataoka M; Department of Surgery, Okayama Saiseikai General Hospital, 1-17-18 Ifuku-cho, Kita-ku, Okayama, Japan.
Yamashita M; Department of Thoracic Surgery, Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama, Japan.
Nakata M; Department of General Thoracic Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, Japan.
Kataoka K; Department of Thoracic Surgery, Iwakuni Clinical Center, 1-1-1 Atagomachi, Iwakuni, Japan.
Yamashita Y; Department of Thoracic Surgery, Kure Medical Center/Chugoku Cancer Center, 3-1 Aoyamacho, Kure, Japan.
Soh J; Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan.
Yoshioka H; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Japan.
Hotta K; Department of Hematology and Oncology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan.
Matsuo K; Division of Molecular Medicine, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Japan.
Sakamoto J; Tokai Central Hospital, 4-6-2 Soharahigashijima, Kakamigahara, Japan.
Toyooka S; Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan.; Department of Clinical Genomic Medicine, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan.
Date H; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoinkawara-cho, Sakyo-ku, Kyoto, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2017 Apr; Vol. 22 (2), pp. 274-282. Date of Electronic Publication: 2016 Dec 05.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Adenocarcinoma/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Large Cell/*drug therapy
Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Squamous Cell/*drug therapy
Lung Neoplasms/*drug therapy
Adenocarcinoma/pathology ; Adult ; Aged ; Carboplatin/administration & dosage ; Carcinoma, Large Cell/pathology ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/pathology ; Chemotherapy, Adjuvant ; Drug Combinations ; Feasibility Studies ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Oxonic Acid/administration & dosage ; Prognosis ; Survival Rate ; Tegafur/administration & dosage ; Young Adult
Czasopismo naukowe
Tytuł :
Long-term Outcomes of Patients With Ground-Glass Opacities Detected Using CT Scanning.
Autorzy :
Sawada S; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan. Electronic address: .
Yamashita N; Division of Clinical Biostatistics, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Sugimoto R; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Ueno T; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Yamashita M; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Pokaż więcej
Źródło :
Chest [Chest] 2017 Feb; Vol. 151 (2), pp. 308-315. Date of Electronic Publication: 2016 Jul 17.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*diagnostic imaging
Adenocarcinoma in Situ/*diagnostic imaging
Lung/*diagnostic imaging
Lung Neoplasms/*diagnostic imaging
Adenocarcinoma/surgery ; Adenocarcinoma in Situ/surgery ; Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Lung/surgery ; Lung Neoplasms/surgery ; Male ; Middle Aged ; Pneumonectomy ; Retrospective Studies ; Time Factors ; Tomography, X-Ray Computed ; Watchful Waiting ; Young Adult
Czasopismo naukowe
Tytuł :
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Autorzy :
Iwata T; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, Japan.
Yoshino I; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, Japan. .
Yoshida S; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, Japan.
Ikeda N; First Department of Surgery, Tokyo Medical University Hospital, 6-7-1, Nishishinjuku, Shinjuku-ku, Tokyo, Japan.
Tsuboi M; Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan.
Asato Y; Department of Thoracic Surgery, Ibaraki Prefectural Central Hospital, 6528, Kobuchi, Kasama, Ibaraki, Japan.
Katakami N; Division of Integrated Oncology, Institute of Biomedical Research and Innovation, 2-2, Minatojima minamicho, Chuo-ku, Kobe, Hyogo, Japan.
Sakamoto K; Department of Respiratory Surgery, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, Kanagawa, Japan.
Yamashita Y; Department of Respiratory Surgery, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, 3-1, Aoyamacho, Kure, Hiroshima, Japan.
Okami J; Department of General Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi Higashinari, Osaka, Osaka, Japan.
Mitsudomi T; Division of Thoracic Surgery, Department of Surgery, Kinki University Faculty of Medicine, 377-2, Ohnohigashi, Sayama, Osaka, Japan.
Yamashita M; Department of Thoracic Surgery, Shikoku Cancer Center, 160, Minamiumemotomachiko, Matsuyama, Ehime, Japan.
Yokouchi H; Department of Pulmonary Medicine, Fukushima Medical University, 1, Hikarigaoka, Fukushima, Fukushima, Japan.
Okubo K; Department of Thoracic Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Okada M; Department of Surgical Oncology, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Hiroshima, Japan.
Takenoyama M; Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1, Notame, Fukuoka Minami-ku, Fukuoka, Japan.
Chida M; Department of General Thoracic Surgery, Dokkyo Medical University, 880, Kitakobayashi, Shimotsugagun Mibumachi, Tochigi, Japan.
Tomii K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1, Minatojimaminamimachi, Chuo-ku, Kobe, Hyogo, Japan.
Matsuura M; Department of Thoracic Surgery, Hiroshima City Hospital, 7-33, Motomachi, Naka-ku, Hiroshima, Hiroshima, Japan.
Azuma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan.
Iwasawa T; Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1, Tomiokahigashi, Kanazawa-ku, Yokohama, Kanagawa, Japan.
Kuwano K; Department of Internal Medicine, Division of Respiratory Medicine, Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan.
Sakai S; Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, 8-1, Kawadacho, Shinjyuku-ku, Tokyo, Japan.
Hiroshima K; Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, 477-96, Ohwada-Shinden, Yachiyo, Chiba, Japan.
Fukuoka J; Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4, Sakamoto, Nagasaki, Nagasaki, Japan.
Yoshimura K; Innovative Clinical Research Center, Kanazawa University Hospital, 13-1, Takaramachi, Kanazawa, Ishikawa, Japan.
Tada H; Department of Thoracic Surgery, Suita Tokushukai Hospital, 21-1, Senriokanishi, Osaka, Japan.
Nakagawa K; Department of Medical Oncology, Kinki University School of Medicine, 377-2, Ohnohigashi, Sayama, Osaka, Japan.
Nakanishi Y; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, Japan.
Pokaż więcej
Corporate Authors :
West Japan Oncology Group
Źródło :
Respiratory research [Respir Res] 2016 Jul 22; Vol. 17 (1), pp. 90. Date of Electronic Publication: 2016 Jul 22.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Pneumonectomy*/adverse effects
Idiopathic Pulmonary Fibrosis/*drug therapy
Lung Neoplasms/*surgery
Pyridones/*administration & dosage
Administration, Oral ; Disease Progression ; Drug Administration Schedule ; Humans ; Idiopathic Pulmonary Fibrosis/diagnostic imaging ; Idiopathic Pulmonary Fibrosis/mortality ; Idiopathic Pulmonary Fibrosis/pathology ; Japan ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Pyridones/adverse effects ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study.
Autorzy :
Kawaguchi T; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan. .
Koh Y; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Ando M; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Ito N; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Takeo S; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Adachi H; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Tagawa T; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Kakegawa S; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Yamashita M; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Kataoka K; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Ichinose Y; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Takeuchi Y; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Serizawa M; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Tamiya A; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Shimizu S; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Yoshimoto N; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Kubo A; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Isa S; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Saka H; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Matsumura A; Tomoya Kawaguchi, Akihiro Tamiya, Shigeki Shimizu, Shun-ichi Isa, and Akihide Matsumura, National Hospital Organization Kinki-chuo Chest Medical Center; Tomoya Kawaguchi and Naoki Yoshimoto, Osaka City University, Osaka; Yasuhiro Koh, Seiichi Kakegawa, Masakuni Serizawa, Akihito Kubo, and Hideo Saka, National Hospital Organization Nagoya Medical Center; Masahiko Ando, Nagoya University, Nagoya; Yasuhiro Koh, Wakayama Medical University, Wakayama; Yasuhiro Koh and Masakuni Serizawa, Shizuoka Cancer Center Research Institute, Shizuoka; Norimasa Ito, National Hospital Organization Matsue Medical Center, Matsue; Sadanori Takeo, National Hospital Organization Kyushu Medical Center; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hirofumi Adachi, National Hospital Organization Hokkaido Cancer Center, Hokkaido; Tsutomu Tagawa, National Hospital Organization Nagasaki Medical Center, Omura; Seiichi Kakegawa, National Hospital Organization Nishigunma National Hospital, Shibukawa; Motohiro Yamashita, National Hospital Organization Shikoku Cancer Center, Matsuyama; Kazuhiko Kataoka, National Hospital Organization Iwakuni Clinical Center, Iwakuni; Yukiyasu Takeuchi, National Hospital Organization Toneyama National Hospital, Toyonaka; Shigeki Shimizu, Hyogo Medical Collage, Hyogo; and Akihito Kubo, Aichi Medical University School of Medicine, Aichi, Japan.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Jul 01; Vol. 34 (19), pp. 2247-57. Date of Electronic Publication: 2016 May 09.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Genes, p53*
Mutation*
Lung Neoplasms/*genetics
Proto-Oncogene Proteins p21(ras)/*genetics
Smoking/*adverse effects
Adult ; Aged ; Aged, 80 and over ; ErbB Receptors/genetics ; Estrogen Receptor beta/analysis ; Female ; Humans ; Lung Neoplasms/virology ; Male ; Middle Aged ; Molecular Epidemiology ; Papillomaviridae/isolation & purification ; Prospective Studies ; Smad4 Protein/genetics
Czasopismo naukowe
Tytuł :
Changes in Post-Operative Complication and Mortality Rates after Lung Cancer Resection in the 20-Year Period 1995-2014.
Autorzy :
Sawada S; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama 791-0280, .
Suehisa H
Ueno T
Yamashita M
Pokaż więcej
Źródło :
Acta medica Okayama [Acta Med Okayama] 2016 Jun; Vol. 70 (3), pp. 183-8.
Typ publikacji :
Journal Article
MeSH Terms :
Lung Neoplasms/*surgery
Postoperative Complications/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Pulmonary metastasectomy from renal cell carcinoma including 3 cases with sarcomatoid component.
Autorzy :
Ueno T; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan. .
Yamashita M; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Sawada S; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Sugimoto R; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Nishijima N; Department of Radiology, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Sugawara Y; Department of Radiology, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Ninomiya I; Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto, Matsuyama, 791-0280, Japan.
Pokaż więcej
Źródło :
General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2016 Mar; Vol. 64 (3), pp. 149-52. Date of Electronic Publication: 2016 Jan 25.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Renal Cell/*secondary
Kidney Neoplasms/*pathology
Lung Neoplasms/*secondary
Metastasectomy/*methods
Pneumonectomy/*methods
Biopsy ; Carcinoma, Renal Cell/diagnosis ; Carcinoma, Renal Cell/surgery ; Disease-Free Survival ; Female ; Humans ; Japan/epidemiology ; Kidney Neoplasms/mortality ; Kidney Neoplasms/surgery ; Lung Neoplasms/diagnosis ; Lung Neoplasms/surgery ; Male ; Metastasectomy/mortality ; Middle Aged ; Pneumonectomy/mortality ; Prognosis ; Survival Rate/trends ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
A proposal of postoperative follow-up pathways for lung cancer.
Autorzy :
Sawada S; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-chou, Matsuyama, Ehime, 791-0280, Japan, .
Shiono S
Yamashita Y
Tagawa T
Ito H
Sato T
Harada H
Yamashita M
Pokaż więcej
Źródło :
General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2015 Apr; Vol. 63 (4), pp. 231-8. Date of Electronic Publication: 2014 Dec 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Lung Neoplasms*/diagnosis
Lung Neoplasms*/mortality
Lung Neoplasms*/surgery
Research Design*
Follow-Up Studies ; Humans ; Japan/epidemiology ; Physical Examination ; Postoperative Period ; Prospective Studies ; Radiography, Thoracic ; Survival Rate/trends
Czasopismo naukowe
Tytuł :
Risk factors for recurrence after lung cancer resection as estimated using the survival tree method.
Autorzy :
Sawada S; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan. Electronic address: .
Yamashita N; Division of Clinical Biostatistics, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Suehisa H; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Yamashita M; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Pokaż więcej
Źródło :
Chest [Chest] 2013 Oct; Vol. 144 (4), pp. 1238-1244.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung/*mortality
Carcinoma, Non-Small-Cell Lung/*surgery
Lung Neoplasms/*mortality
Lung Neoplasms/*surgery
Neoplasm Recurrence, Local/*mortality
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Survival Rate
Czasopismo naukowe
Tytuł :
Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
Autorzy :
Tanabe Y; Department of Diagnostic Radiology, National Hospital Organization, Shikoku Cancer Center, Kou-160 Minamiumemoto-machi, Matsuyama, Ehime, 791-0280, Japan, .
Sugawara Y
Nishimura R
Hosokawa K
Kajihara M
Shimizu T
Takahashi T
Sakai S
Sawada S
Yamashita M
Ohtani H
Pokaż więcej
Źródło :
Annals of nuclear medicine [Ann Nucl Med] 2013 Oct; Vol. 27 (8), pp. 781-5. Date of Electronic Publication: 2013 Jun 12.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*/metabolism
Positron-Emission Tomography*
Tomography, X-Ray Computed*
Carcinoid Tumor/*diagnostic imaging
Lung Neoplasms/*diagnostic imaging
Aged ; Biological Transport ; Carcinoid Tumor/metabolism ; Humans ; Lung Neoplasms/metabolism ; Male ; Multimodal Imaging
Czasopismo naukowe
Tytuł :
Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Autorzy :
Nakajima N; Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou-160, Minamiumemoto-machi, Matsuyama, Ehime 791-0280, Japan. />Sugawara Y
Kataoka M
Hamamoto Y
Ochi T
Sakai S
Takahashi T
Kajihara M
Teramoto N
Yamashita M
Mochizuki T
Pokaż więcej
Źródło :
Annals of nuclear medicine [Ann Nucl Med] 2013 Apr; Vol. 27 (3), pp. 261-70. Date of Electronic Publication: 2013 Jan 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Fluorodeoxyglucose F18*/metabolism
Multimodal Imaging*
Positron-Emission Tomography*
Tomography, X-Ray Computed*
Lung Neoplasms/*diagnostic imaging
Lung Neoplasms/*radiotherapy
Pulmonary Fibrosis/*diagnostic imaging
Radiation Injuries/*diagnostic imaging
Radiosurgery/*adverse effects
Aged ; Aged, 80 and over ; Biological Transport ; Diagnosis, Differential ; Female ; Humans ; Lung Neoplasms/metabolism ; Male ; Middle Aged ; Pulmonary Fibrosis/metabolism ; Radiation Injuries/metabolism ; Recurrence
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies